Drugs & TargetsFree FDA accepts Celyad IND application for CYAD-101, a non-gene edited allogeneic CAR-T candidate July 27, 2018Vol.44 No.30
Drugs & TargetsFree BMS, Tsinghua University to develop therapies for autoimmune diseases, cancer July 27, 2018Vol.44 No.30
Drugs & Targets FDA grants breakthrough designation for Tecentriq + Avastin as first-line treatment for hepatocellular carcinoma July 20, 2018Vol.44 No.29
Drugs & Targets BMS and Gritstone to evaluate neoantigen immunotherapy in solid tumors July 20, 2018Vol.44 No.29
Drugs & Targets FDA grants accelerated approval to Yervoy for MSI-H or dMMR metastatic colorectal cancer July 13, 2018Vol.44 No.28
Drugs & Targets FDA grants Priority Review to Merck’s sBLA for Keytruda for advanced hepatocellular carcinoma July 13, 2018Vol.44 No.28
